yttrium radioisotopes has been researched along with Leukemia, Myeloid, Acute in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansell, SM; Burnette, BL; Colgan, JP; Epperla, N; Habermann, TM; Inwards, DJ; Johnston, PB; Macon, WR; Markovic, SN; Micallef, IN; Nowakowski, GS; Pham, AQ; Porrata, LF; Ristow, KM; Wiseman, GA; Witzig, TE | 1 |
| Baum, RP; Bodei, L; Cremonesi, M; Drozdov, I; Grana, CM; Kidd, M; Krenning, EP; Kwekkeboom, DJ; Lepensky, C; Modlin, IM; Paganelli, G | 1 |
| Beer, AJ; Bunjes, D; Glatting, G; Kletting, P; Maaß, C; Mahren, B | 1 |
| Glatting, G; Kletting, P; Kull, T; Reske, SN | 1 |
| Buttiglieri, S; Carlo-Stella, C; Devizzi, L; Di Nicola, M; Giacomini, A; Gianni, AM; Guidetti, A; Locatelli, SL; Mariani, L; Miceli, R; Passera, R; Risso, A; Ruella, M; Tarella, C; Testi, A | 1 |
| Dewald, G; Gordon, LI; Kent, SA; Multani, P; Nabhan, C; Peterson, LA; Tallman, MS | 1 |
| Dierckx, RA; Otte, A | 1 |
| Czuczman, MS; Darif, M; Emmanouilides, C; Gordon, LI; Molina, A; Revell, S; Vo, K; Witzig, TE | 1 |
| Boni, G; Cecconi, N; Focosi, D; Galimberti, S; Orciuolo, E; Petrini, M | 1 |
2 trial(s) available for yttrium radioisotopes and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Leukemia, Myeloid, Acute; Lutetium; Male; Middle Aged; Myelodysplastic Syndromes; Neuroendocrine Tumors; Octreotide; Radiation Dosage; Radiopharmaceuticals; Receptors, Peptide; Yttrium Radioisotopes | 2015 |
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Topics: Adult; Aged; Antibodies, Monoclonal; Bone Marrow; Female; Follow-Up Studies; Granulocyte-Macrophage Progenitor Cells; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radioimmunotherapy; Risk; Telomere; Yttrium Radioisotopes | 2011 |
7 other study(ies) available for yttrium radioisotopes and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Chemotherapy, Adjuvant; Databases, Factual; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radioimmunotherapy; Risk Factors; Rituximab; Vidarabine; Young Adult; Yttrium Radioisotopes | 2017 |
Population-Based Modeling Improves Treatment Planning Before (90)Y-Labeled Anti-CD66 Antibody Radioimmunotherapy.
Topics: Algorithms; Antigen-Antibody Reactions; Antigens, CD; Bayes Theorem; Cell Adhesion Molecules; Humans; Immunotoxins; Leukemia, Myeloid, Acute; Models, Biological; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioimmunotherapy; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes | 2015 |
Comparing time activity curves using the Akaike information criterion.
Topics: Adult; Aged; Antigens, CD; Cell Adhesion Molecules; Female; Humans; Indium Radioisotopes; Kinetics; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Statistical; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiometry; Radiopharmaceuticals; Yttrium Radioisotopes | 2009 |
Secondary acute myelogenous leukemia with MLL gene rearrangement following radioimmunotherapy (RAIT) for non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antigens, CD20; Chromosomes, Human, Pair 11; DNA-Binding Proteins; Female; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Proto-Oncogenes; Radioimmunotherapy; Transcription Factors; Yttrium Radioisotopes | 2002 |
Myelosuppressive side-effects of radioimmunotherapy of non-Hodgkin's lymphoma: is there an increased risk?
Topics: Alkylating Agents; Antibodies, Monoclonal; Humans; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Prognosis; Radioimmunotherapy; Risk; Time Factors; Yttrium Radioisotopes | 2005 |
Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Radioimmunotherapy; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma.
Topics: Antibodies, Monoclonal; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Middle Aged; Neoplasms, Second Primary; Radioimmunotherapy; Yttrium Radioisotopes | 2008 |